Can taking amitriptyline tablets stop long-term pain from shingles?
Shingles is an infection that causes a painful, blistering rash. For some people, severe nerve pain carries on for months or even years after the rash clears up. This study is testing whether taking a low dose of a medicine called amitriptyline soon after the rash appears can prevent this lasting nerve pain. Amitriptyline is already used to treat long-term nerve pain, but doctors want to know if taking it early stops the pain from setting in at all. The trial is open to people aged 50 or over who have had a shingles rash for less than six days. Participants take one tablet each night for 10 weeks. Half will receive low-dose amitriptyline and half will take a dummy pill (placebo). Researchers will assess everyone's pain after three months to see if the medicine helped.
At a glance
What is this study about?
Shingles is caused by the same virus that causes chickenpox. After you have chickenpox, the virus stays asleep in your body's nerve cells. If it wakes up years later, it causes shingles, leading to a painful rash on one side of the body. While the rash usually clears up in a few weeks, the nerves can sometimes stay damaged and inflamed. This causes burning, aching, or shooting pain that can last for months or years, which can be very difficult to treat.
This trial is looking at a well-known tablet called amitriptyline. Doctors already prescribe amitriptyline to help ease existing nerve pain. In this study, researchers want to see if starting amitriptyline right at the beginning of a shingles infection can protect the nerves and stop long-term pain from ever starting.
Finding a simple, inexpensive way to prevent this lasting pain would make a huge difference to thousands of people each year. Because amitriptyline is already widely available and low-cost, positive results from this trial could quickly change how the NHS treats shingles in older adults.
Key takeaways
- Tests whether low-dose amitriptyline can stop long-term nerve pain after shingles.
- Open to adults aged 50 and over who noticed their shingles rash within the past six days.
- Involves taking one tablet every night for 10 weeks (either the real medicine or a dummy pill).
- Your pain will be checked at three months after your rash started.
- Taking part is completely voluntary and will not affect your standard NHS care.
Who may be eligible?
You may be able to join this study if you are aged 50 or older, have been diagnosed with shingles by your GP, and your rash first appeared within the last six days (144 hours). You must also be able to understand the study details and give your consent to take part.
You cannot take part if you have had shingles twice or more before, or if you have certain medical conditions. These include heart conditions (such as a recent heart attack, heart failure, or an irregular heartbeat), severe liver disease, an overactive thyroid, trouble passing urine, a weakened immune system, or feelings of suicide. Women who are pregnant, planning a pregnancy in the next three months, or breastfeeding are also unable to join.
Finally, you cannot take part if you already take certain medicines, particularly antidepressants known as tricyclics or MAOIs, or medicines that affect your heart rhythm. If you are taking part in another clinical drug trial, you will not be able to join.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 50 or over.
- A doctor has diagnosed me with shingles.
- My shingles rash started less than six days (144 hours) ago.
- I have not had shingles more than once in the past.
- I do not have serious heart conditions or severe liver disease.
- I am not currently taking antidepressant tablets or pregnant/breastfeeding.
What does participation involve?
Taking part in this study lasts for around three months. If you join, you will be asked to take one tablet every night before bed for 10 weeks. You will be placed into one of two groups by chance: one group takes a low dose of amitriptyline, and the other takes a dummy tablet (placebo) that looks identical. Neither you nor your doctor will know which tablet you are taking during the study.
You will continue to receive your usual shingles care from your GP alongside the trial tablets. You will be asked to fill in simple questionnaires about your symptoms and any pain you feel. The main health check happens at 90 days (about three months) after your rash first appeared, where researchers will assess whether you have any ongoing nerve pain.
Potential risks and benefits
Locations (3)
- University of BristolApproximateBristol, England
- University of OxfordApproximateOxford, England
- University of SouthamptonApproximateSouthampton, England
Common questions
What is a placebo and why is it used?
A placebo is a dummy tablet that looks and tastes identical to the real medicine but contains no active drug. Researchers use it to see whether any improvements are truly caused by amitriptyline or just by the act of taking a pill.
Can I still take my regular shingles medication?
Yes. Taking part does not stop you from receiving standard treatments, such as antiviral tablets or usual painkillers, prescribed by your GP.
Is amitriptyline an antidepressant?
Yes, in higher doses it was originally used for depression. In this study, it is used at a much lower dose specifically aimed at calming irritated nerves and preventing nerve pain.
Will taking part cost me anything?
No, the study tablets are provided free of charge, and you do not have to pay to take part in NHS-funded research.
What happens if I feel unwell during the trial?
You will be given contact details for the study team to report any problems. You can also contact your GP as normal, and you can stop taking the study tablets at any time.
How to find out more
Christine Hawkins
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.